drugset / Trial / NCT01938235

Exenatide for Myocardial Protection During Reperfusion Study

NCT01938235

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to assess the effect of exenatide on myocardial injury in patients undergoing emergent percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction or heart attack (STEMI).

Timeline

Start
2014-02
Primary completion
2017-07
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide 1.2 ug Intravenous
Subject Exenatide Peptide 1.9 ug Intravenous

Indications